Rationale and trial design of RIBOLARIS: A phase II trial of neoadjuvant and adjuvant ribociclib plus endocrine therapy for clinically high-risk HR+/HER2-negative breast cancer

Paul Cottu, Tomas Pascual, Jerôme Lemonnier, Huilin Hu, Estelle Roux, Roisin M Connolly, Cynthia X Ma, Antonio C Wolff, Thayane Crestani, Pablo Tolosa, Juan M Ferrero-Cafiero, Antonio Mulero-Sánchez, Fernando Salvador, Guillermo Villacampa, Joaquín Gavilá, Thibault de La Motte Rouge, Aleix Prat · 2026

Read Rationale and trial design of RIBOLARIS: A phase II trial of neoadjuvant and adjuvant ribociclib plus endocrine therapy for clinically high-risk HR+/HER2-negative breast cancer by Paul Cottu, Tomas Pascual, Jerôme Lemonnier, Huilin Hu, Estelle Roux, Roisin M Connolly, Cynthia X Ma, Antonio C Wolff, Thayane Crestani, Pablo Tolosa, Juan M Ferrero-Cafiero, Antonio Mulero-Sánchez, Fernando Salvador, Guillermo Villacampa, Joaquín Gavilá, Thibault de La Motte Rouge, Aleix Prat (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13473800.txt.

Description

A peer-reviewed research article from Europe PMC (2026). Background:Despite advances in endocrine therapy, patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) early breast cancer (eBC) remain at risk of recurrence (ROR). Chemotherapy is often used in high-risk cases, but not all patients benefit.Objectives:To evaluate whether chemotherapy can be safely omitted in patients with stage II, grade 2/3 HR+/HER2− eBC who convert to low genomic risk (ROR-low) following neoadjuvant ribociclib plus letrozole.Methods:RIBOLARIS (NCT05296746) is an open-label, multicenter phase II trial in patients with stage II, grade 2 or

Catalog record

CREATORPaul Cottu, Tomas Pascual, Jerôme Lemonnier, Huilin Hu, Estelle Roux, Roisin M Connolly, Cynthia X Ma, Antonio C Wolff, Thayane Crestani, Pablo Tolosa, Juan M Ferrero-Cafiero, Antonio Mulero-Sánchez, Fernando Salvador, Guillermo Villacampa, Joaquín Gavilá, Thibault de La Motte Rouge, Aleix Prat
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE69 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13473800

Browse the full library · About the Tower of Babel